"Sahajanand Medical Technologies PVT.LTD (SMTPL) is the first stent manufacturing company outside the US to launch the Paclitaxel Eluting 'Infinnium Stent' - used in nearly 25 countries worldwide - and the Sirolimus Eluting 'Supralimus Stent'.
- SIMPLE 1 data, presented at Euro PCR 2003 with extended follow-up at TCT 2004, has impressed interventionalists worldwide.
- SIMPLE 2, a prospective multi-center trial, has completed enrollment in 8 centers. Watch for 6-month follow-up data at TCT 2005. Once again 'East meets West'".
Source : TCTMD e-letter - What's New the Week of July 5, 2005
To access the EuroPCR online news, click here.
Strategic solutions for Pharmaceutical, Biotechnology and Medical Device Companies:
"As a leading global provider of discovery and development services and products for pharmaceutical, biotechnology and medical device companies, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients maximize the return on their R&D investments. With proven discovery through post-market resources, the company also offers compound partnering opportunities. PPD has more than 7,100 professionals worldwide with offices in 28 countries."
Treatment of Coronary Artery Disease :
Heart Center Patient Programme: click here.
Source: Heart Center Online.